Drew Estate’s Deadwood Tobacco Co. “The Girl With No Name” Connecticut Shade Robusto Surfaces Exclusively at JRCigars.com and Cigars.com

September 7, 2023 By Matthew Tabacco

Subtle, mysterious and hard to pin down, the Deadwood Tobacco Co. “The Girl With No Name” has once again changed her appearance and is riding her husky black stallion to a new locale.

“Drifting across the Old West’s High Plains to the Badlands of South Dakota and countless locations in between, Deadwood Tobacco Co.’s ‘The Girl With No Name,’ has thrown countless pursuers off her trail,” says Vaughn Boyd, Deadwood Tobacco Co.’s Founder and former owner, who partnered with Drew Estate to uncover the notorious Deadwood ladies’ sultry tales one puff at a time. “The voluptuous and rebellious temptress has turned up once again and only the most resourceful bandits and bounty hunters have any hope of roping her in.”

The Deadwood Tobacco Co. “The Girl With No Name” Connecticut Shade Robusto (5 x 50) is now available exclusively at JR Cigars and Cigars.com. Featuring the iconic Deadwood cigars’ Sugar Skull artwork on both the band and box, the latest Deadwood “The Girl With No Name” is available in both 20-count boxes and 5-packs, and features a succulent Ecuadorian-grown Connecticut Shade wrapper that is blended with bewitching exotic tobaccos to enchant anyone lucky enough to track her down.

“Deadwood’s ‘Girl With No Name’ is such a crazy dope series,” explains Jonathan Drew, Founder and President of Drew Estate. “Gives me this strange feeling, somewhere between U2’s ‘Street With No Name’ and the movie ‘Girl with the Dragon Tattoo.’ When ya smoke one, ya feel like you’re a movie star.”

Related Posts

Perdomo Hires Michael Giannini

January 24, 2025 By Matthew Tabacco
Today, Perdomo Cigars announced that Michael Giannini, a longtime executive and figure of the cigar industry, has joined their Sales & Marketing team. Read more
FDA Updates

Cigar Industry Scores Second Win Against FDA in Regulation Case

January 24, 2025 By Matthew Tabacco
Today, the United States Court of Appeals for the District of Columbia issued its decision in CAA et al. v. FDA. Read more